In recent months, three firms have received US Food and Drug Administration clearance for smartphone devices that allow patient-operated urinalysis testing.
The consulting practice will advise labs on issues such as technology, process improvements, and workforce management. It expects to launch in the US next year.
Atomo's tests use the firm's AtomoRapid technology to detect the presence of HIV antibodies from a finger prick of blood and provides results within 15 minutes.
